Annual Drug Patent Expirations for ZONTIVITY
Zontivity is a drug marketed by Xspire Pharma and is included in one NDA. It is available from one supplier. There are two patents protecting this drug.
This drug has one hundred and fifty-five patent family members in thirty-seven countries.
The generic ingredient in ZONTIVITY is vorapaxar sulfate. One supplier is listed for this compound. Additional details are available on the vorapaxar sulfate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
